CFDE Data Portal | Search IFNA20P

	Label	Description
	IFNA20P associations Collection (Entity type)	Associations for IFNA20P_associations
	IFNA20P associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	IFNA20P Gene (Entity type)	ENSG00000226393 - interferon alpha 20, pseudogene
	GSE77108 saha 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE203329 HCC knockout 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 8 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE101788 GSE101791 MYC inhibition 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE95302 tamoxifen 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 2 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202744 CDK9 inhibition Toyocamycin 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

IFNA20P associations

Associations for IFNA20P_associations

IFNA20P associations.tsv

A file from IDG as part of the Harmonizome project

IFNA20P

ENSG00000226393 - interferon alpha 20, pseudogene

GSE77108 saha 0 v 1 human dn

A Gene Set from LINCS

GSE203329 HCC knockout 2 v 1 human up

A Gene Set from LINCS

GSE135514 dasatinib 8 v 9 human up

A Gene Set from LINCS

GSE101788 GSE101791 MYC inhibition 0 v 1 human up

A Gene Set from LINCS

GSE95302 tamoxifen 1 v 4 human up

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 2 v 9 human dn

A Gene Set from LINCS

GSE202744 CDK9 inhibition Toyocamycin 1 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.